Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Monday 20 October 2014 4:10 am  |  Updated:  Friday 07 June 2019 2:01 pm

Shire interim finance chief James Bowling switches to Severn Trent

By: Guy Bentley

Add as a preferred source on Google

Shire's interim chief financial officer (CFO) James Bowling has informed the company's board that he will be stepping down to pursue a career at the FTSE 100 water company Severn Trent.

Bowling will exit Shire at the end of the first quarter of 2015.

Flemming Ornskov, Shire's Chief Executive Officer, commented:

James has helped build and lead a high-quality finance team at Shire. We are very grateful to him for his interim leadership over the past seven months, and his many contributions to Shire in almost ten years with the Company. We wish him well in his future endeavors.

Over the weekend, the Sunday Times reported Shire is in discussions with acquisition targets including NPS Pharmaceuticals and biopharmaceutical firm Cubist.

AbbVie recommended its shareholders vote against the proposed $54bn deal to buy UK drugmaker Shire last week, ending the takeover bid and knocking Shire’s shares down nearly 30 per cent by Friday.

AbbVie said it would rethink the acquisition in the wake of the US Treasury’s plans to curb so-called tax inversion deals. Shire is due to publish its third quarter financial results at the end of this week.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Company
  • Severn Trent

Trending Articles

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

  • Burnham’s devolution drive could ‘push 90,000 jobs out of London’

  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

  • BM3EAC Corp. 2026 Semi-Annual Report

  • London IPO candidate Utmost sees inflows slide

More from Morning Wire

  • Mark Kleinman: Nationwide’s pride should be dented by member election bid

    Business
    Mark Kleinman is Sky News' City Editor and writes a column for Morning Wire
  • Hiscox finance chief: London’s AI adoption is too slow

    Opinion
    Paul Cooper, a man in a navy suit, gestures during a business meeting at a conference table.
  • St James’s Place suffers £1bn hit to flows as investors look to dodge pension tax

    Investing
    St James's Place (SJP) (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)
  • Exclusive: Sydney Opera House and Gherkin designer Arup loses finance chief

    Consulting
    Sydney Opera House at dawn with illuminated sails reflecting on calm water and a cloudy sky
  • Brightfin Appoints Preeti Shukla as Chief Product and AI Officer

    Business Wire
  • QX Global Group Appoints Vijay Pahuja as Group Chief Executive Officer

    Business Wire
  • FTSE 100 Segro agrees to £14bn takeover by Prologis

    Property
    David Sleath, Chief Executive Officer, delivering a speech at a business conference with a focused expression.
  • As it happened: Stocks rise but oil tops $95; inflation eases

    Markets
    Man in suit and red tie speaking at a podium to an audience in a modern building.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook